Copyright Reports & Markets. All rights reserved.

Global Pneumonia Vaccine Sales Market Report 2021

Request for Sample of this report
Buy now

1 Pneumonia Vaccine Market Overview

  • 1.1 Pneumonia Vaccine Product Scope
  • 1.2 Pneumonia Vaccine Segment by Type
    • 1.2.1 Global Pneumonia Vaccine Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Pneumococcal Conjugate Vaccine (PCV13)
    • 1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
  • 1.3 Pneumonia Vaccine Segment by Application
    • 1.3.1 Global Pneumonia Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Pneumonia
    • 1.3.3 Meningitis
    • 1.3.4 Sepsis
  • 1.4 Pneumonia Vaccine Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Pneumonia Vaccine Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Pneumonia Vaccine Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Pneumonia Vaccine Price Trends (2016-2027)

2 Pneumonia Vaccine Estimates and Forecasts by Region

  • 2.1 Global Pneumonia Vaccine Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Pneumonia Vaccine Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Pneumonia Vaccine Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Pneumonia Vaccine Revenue Market Share by Region (2016-2021)
  • 2.3 Global Pneumonia Vaccine Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Pneumonia Vaccine Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Pneumonia Vaccine Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Pneumonia Vaccine Estimates and Projections (2016-2027)
    • 2.4.2 Europe Pneumonia Vaccine Estimates and Projections (2016-2027)
    • 2.4.3 China Pneumonia Vaccine Estimates and Projections (2016-2027)
    • 2.4.4 Japan Pneumonia Vaccine Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Pneumonia Vaccine Estimates and Projections (2016-2027)
    • 2.4.6 India Pneumonia Vaccine Estimates and Projections (2016-2027)

3 Global Pneumonia Vaccine Competition Landscape by Players

  • 3.1 Global Top Pneumonia Vaccine Players by Sales (2016-2021)
  • 3.2 Global Top Pneumonia Vaccine Players by Revenue (2016-2021)
  • 3.3 Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pneumonia Vaccine as of 2020)
  • 3.4 Global Pneumonia Vaccine Average Price by Company (2016-2021)
  • 3.5 Manufacturers Pneumonia Vaccine Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Pneumonia Vaccine Market Size by Type

  • 4.1 Global Pneumonia Vaccine Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Pneumonia Vaccine Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Pneumonia Vaccine Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Pneumonia Vaccine Price by Type (2016-2021)
  • 4.2 Global Pneumonia Vaccine Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Pneumonia Vaccine Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Pneumonia Vaccine Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Pneumonia Vaccine Price Forecast by Type (2022-2027)

5 Global Pneumonia Vaccine Market Size by Application

  • 5.1 Global Pneumonia Vaccine Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Pneumonia Vaccine Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Pneumonia Vaccine Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Pneumonia Vaccine Price by Application (2016-2021)
  • 5.2 Global Pneumonia Vaccine Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Pneumonia Vaccine Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Pneumonia Vaccine Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Pneumonia Vaccine Price Forecast by Application (2022-2027)

6 North America Pneumonia Vaccine Market Facts & Figures

  • 6.1 North America Pneumonia Vaccine Sales by Company
    • 6.1.1 North America Pneumonia Vaccine Sales by Company (2016-2021)
    • 6.1.2 North America Pneumonia Vaccine Revenue by Company (2016-2021)
  • 6.2 North America Pneumonia Vaccine Sales Breakdown by Type
    • 6.2.1 North America Pneumonia Vaccine Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Pneumonia Vaccine Sales Breakdown by Type (2022-2027)
  • 6.3 North America Pneumonia Vaccine Sales Breakdown by Application
    • 6.3.1 North America Pneumonia Vaccine Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Pneumonia Vaccine Sales Breakdown by Application (2022-2027)

7 Europe Pneumonia Vaccine Market Facts & Figures

  • 7.1 Europe Pneumonia Vaccine Sales by Company
    • 7.1.1 Europe Pneumonia Vaccine Sales by Company (2016-2021)
    • 7.1.2 Europe Pneumonia Vaccine Revenue by Company (2016-2021)
  • 7.2 Europe Pneumonia Vaccine Sales Breakdown by Type
    • 7.2.1 Europe Pneumonia Vaccine Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Pneumonia Vaccine Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Pneumonia Vaccine Sales Breakdown by Application
    • 7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Pneumonia Vaccine Market Facts & Figures

  • 8.1 China Pneumonia Vaccine Sales by Company
    • 8.1.1 China Pneumonia Vaccine Sales by Company (2016-2021)
    • 8.1.2 China Pneumonia Vaccine Revenue by Company (2016-2021)
  • 8.2 China Pneumonia Vaccine Sales Breakdown by Type
    • 8.2.1 China Pneumonia Vaccine Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Pneumonia Vaccine Sales Breakdown by Type (2022-2027)
  • 8.3 China Pneumonia Vaccine Sales Breakdown by Application
    • 8.3.1 China 241 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 241 Sales Breakdown by Application (2022-2027)

9 Japan Pneumonia Vaccine Market Facts & Figures

  • 9.1 Japan Pneumonia Vaccine Sales by Company
    • 9.1.1 Japan Pneumonia Vaccine Sales by Company (2016-2021)
    • 9.1.2 Japan Pneumonia Vaccine Revenue by Company (2016-2021)
  • 9.2 Japan Pneumonia Vaccine Sales Breakdown by Type
    • 9.2.1 Japan Pneumonia Vaccine Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Pneumonia Vaccine Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Pneumonia Vaccine Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Pneumonia Vaccine Market Facts & Figures

  • 10.1 Southeast Asia Pneumonia Vaccine Sales by Company
    • 10.1.1 Southeast Asia Pneumonia Vaccine Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Pneumonia Vaccine Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Pneumonia Vaccine Sales Breakdown by Type
    • 10.2.1 Southeast Asia Pneumonia Vaccine Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Pneumonia Vaccine Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Pneumonia Vaccine Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Pneumonia Vaccine Market Facts & Figures

  • 11.1 India Pneumonia Vaccine Sales by Company
    • 11.1.1 India Pneumonia Vaccine Sales by Company (2016-2021)
    • 11.1.2 India Pneumonia Vaccine Revenue by Company (2016-2021)
  • 11.2 India Pneumonia Vaccine Sales Breakdown by Type
    • 11.2.1 India Pneumonia Vaccine Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Pneumonia Vaccine Sales Breakdown by Type (2022-2027)
  • 11.3 India Pneumonia Vaccine Sales Breakdown by Application
    • 11.3.1 India Pneumonia Vaccine Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Pneumonia Vaccine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Pneumonia Vaccine Business

  • 12.1 Pfizer Inc.
    • 12.1.1 Pfizer Inc. Corporation Information
    • 12.1.2 Pfizer Inc. Business Overview
    • 12.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Pfizer Inc. Pneumonia Vaccine Products Offered
    • 12.1.5 Pfizer Inc. Recent Development
  • 12.2 Glaxosmithkline Plc.
    • 12.2.1 Glaxosmithkline Plc. Corporation Information
    • 12.2.2 Glaxosmithkline Plc. Business Overview
    • 12.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Products Offered
    • 12.2.5 Glaxosmithkline Plc. Recent Development
  • 12.3 Merck & Co., Inc.
    • 12.3.1 Merck & Co., Inc. Corporation Information
    • 12.3.2 Merck & Co., Inc. Business Overview
    • 12.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Merck & Co., Inc. Pneumonia Vaccine Products Offered
    • 12.3.5 Merck & Co., Inc. Recent Development
  • 12.4 Sanofi Pasteur
    • 12.4.1 Sanofi Pasteur Corporation Information
    • 12.4.2 Sanofi Pasteur Business Overview
    • 12.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Sanofi Pasteur Pneumonia Vaccine Products Offered
    • 12.4.5 Sanofi Pasteur Recent Development
  • 12.5 Serum Institute of India Pvt. Ltd.
    • 12.5.1 Serum Institute of India Pvt. Ltd. Corporation Information
    • 12.5.2 Serum Institute of India Pvt. Ltd. Business Overview
    • 12.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Products Offered
    • 12.5.5 Serum Institute of India Pvt. Ltd. Recent Development
  • 12.6 Johnson & Johnson
    • 12.6.1 Johnson & Johnson Corporation Information
    • 12.6.2 Johnson & Johnson Business Overview
    • 12.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Johnson & Johnson Pneumonia Vaccine Products Offered
    • 12.6.5 Johnson & Johnson Recent Development
  • 12.7 Astellas Pharma Inc.
    • 12.7.1 Astellas Pharma Inc. Corporation Information
    • 12.7.2 Astellas Pharma Inc. Business Overview
    • 12.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Astellas Pharma Inc. Pneumonia Vaccine Products Offered
    • 12.7.5 Astellas Pharma Inc. Recent Development
  • 12.8 Astrazeneca Plc.
    • 12.8.1 Astrazeneca Plc. Corporation Information
    • 12.8.2 Astrazeneca Plc. Business Overview
    • 12.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Astrazeneca Plc. Pneumonia Vaccine Products Offered
    • 12.8.5 Astrazeneca Plc. Recent Development
  • 12.9 CSL Limited
    • 12.9.1 CSL Limited Corporation Information
    • 12.9.2 CSL Limited Business Overview
    • 12.9.3 CSL Limited Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 CSL Limited Pneumonia Vaccine Products Offered
    • 12.9.5 CSL Limited Recent Development
  • 12.10 Emergent Biosolutions
    • 12.10.1 Emergent Biosolutions Corporation Information
    • 12.10.2 Emergent Biosolutions Business Overview
    • 12.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Emergent Biosolutions Pneumonia Vaccine Products Offered
    • 12.10.5 Emergent Biosolutions Recent Development

13 Pneumonia Vaccine Manufacturing Cost Analysis

  • 13.1 Pneumonia Vaccine Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Pneumonia Vaccine
  • 13.4 Pneumonia Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Pneumonia Vaccine Distributors List
  • 14.3 Pneumonia Vaccine Customers

15 Market Dynamics

  • 15.1 Pneumonia Vaccine Market Trends
  • 15.2 Pneumonia Vaccine Drivers
  • 15.3 Pneumonia Vaccine Market Challenges
  • 15.4 Pneumonia Vaccine Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Pneumonia Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Pneumococcal Conjugate Vaccine (PCV13)
    Pneumococcal Polysaccharide Vaccine (PPSV23)

    Segment by Application
    Pneumonia
    Meningitis
    Sepsis

    The Pneumonia Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Pneumonia Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Pfizer Inc.
    Glaxosmithkline Plc.
    Merck & Co., Inc.
    Sanofi Pasteur
    Serum Institute of India Pvt. Ltd.
    Johnson & Johnson
    Astellas Pharma Inc.
    Astrazeneca Plc.
    CSL Limited
    Emergent Biosolutions

    Buy now